L. Zoni-berisso-m, . Carazza-t, and . Domenicucci-s, Epidemiology of atrial fibrillation: European perspective, Clin Epidemiol. juin, p.213, 2014.

F. Nguyen-bl, C. Mc, C. Ls, and . Masroor-s, Histopathological substrate for chronic atrial fibrillation in humans, Heart Rhythm. avr, vol.6, issue.4, pp.454-60, 2009.

. Go-as, E. M. Hylek, P. Ka, C. Y. , H. Le et al., Prevalence of

, Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study

, JAMA. 9 mai, vol.285, issue.18, pp.2370-2375, 2001.

Y. Miyasaka, G. Barnes-me, C. Bj, . Ss, A. Bailey-kr et al., Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Circulation. 11 juill, vol.114, issue.2, pp.119-144, 1980.

. Bassand-j-p.-fibrillation-atriale,

. Kirchhof-p, . Benussi-s, . Kotecha-d, . Ahlsson-a, . Atar-d et al., ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, 2016.

, Eur Heart J, vol.37, issue.38, pp.2893-962, 2016.

A. Kannel-wb, . Rd, . Savage-dd, and . Mcnamara-pm, Coronary heart disease and atrial fibrillation: the Framingham Study, Am Heart J. août, vol.106, issue.2, pp.389-96, 1983.

L. Dm, W. Tj, L. Ep, L. Mg, . Levy-d et al., Lifetime risk for development of atrial fibrillation: the Framingham Heart Study, Circulation. 31 août, vol.110, issue.9, pp.1042-1048, 2004.

B. Feinberg-wm, . Jl, . Laupacis-a, H. R. Kronmal-r, and . Prevalence, Age

, Gender of Patients With Atrial Fibrillation: Analysis and Implications, Arch Intern Med. 13 mars, vol.155, issue.5, pp.469-73, 1995.

B. Bacquer-dd, . Gd, and . Kornitzer-m, Prevalences of ECG findings in large population based samples of men and women, Heart. 1 déc, vol.84, issue.6, pp.625-658, 2000.

A. Hassink-rj, . Ht, J. Ruskin, and . Keane-d, Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation, J Am Coll Cardiol. 17 sept, vol.42, issue.6, pp.1108-1122, 2003.

N. Sanders-p, . Cj, . Dubois-r, . Takahashi-y, . Hocini-m et al., Frequency mapping of the pulmonary veins in paroxysmal versus permanent atrial fibrillation, J Cardiovasc Electrophysiol. sept, vol.17, issue.9, pp.965-72, 2006.

J. Haïssaguerre-m, G. Shah-dc, . Takahashi-a, E. T. Lavergne-t, and . Al,

, Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci, Circulation. 28 mars, vol.101, issue.12, pp.1409-1426, 2000.

W. Tj, J. M. Massaro, V. Levy-d, W. Rs, D. Pa et al., A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA. 27 août, vol.290, issue.8, pp.1049-56, 2003.

A. Kannel-wb, . Rd, . Savage-dd, and . Mcnamara-pm, Epidemiologic Features of Chronic

, Atrial Fibrillation, N Engl J Med. 29 avr, vol.306, issue.17, pp.1018-1040, 1982.

W. Benjamin-ej, D. Pa, . Rb, H. Silbershatz, K. Wb et al.,

, Atrial Fibrillation on the Risk of Death: The Framingham Heart Study, Circulation. 8 sept, vol.98, issue.10, pp.946-52, 1998.

J. Gajewski and . Singer-rb, Mortality in an insured population with atrial fibrillation, JAMA. 17 avr, vol.245, issue.15, pp.1540-1544, 1981.

H. Van-gelder-ic, B. Ve, K. Ha, . Jh, . Kamp-o et al., A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation, INVESTIGATORS TAFFI OF RM (AFFIRM), vol.347, pp.1834-1874, 2002.

M. Gf, K. Vasan-rs, . Mj, H. Parise, W. Tj et al., Pulse pressure and risk of new-onset atrial fibrillation, JAMA. 21 févr, vol.297, issue.7, pp.709-724, 2007.

. Taboulet-p, Aspects électrocardiograhiques de la fibrillation auriculaire, Ann Fr Médecine Urgence. 1 janv, vol.2, issue.1, pp.27-34, 2012.

G. As, H. Do, . Herges-rm, N. J. Olson-ej, K. T. et al., Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation, J Am Coll Cardiol. 6 févr, vol.49, issue.5, pp.565-71, 2007.

M. Kanagala-r, . Ns, P. A. Friedman, A. Nm, G. Bj et al.,

, Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation, Circulation. 27 mai, vol.107, pp.2589-94, 1920.

B. Mehra-r, S. E. Ej, G. Dj, K. Nawabit-r, E. T. Hl et al., Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study, Am J Respir Crit Care Med. 15 avr, vol.173, issue.8, pp.910-916, 2006.

. Hijazi-z, J. Oldgren, A. U. , C. Sj, E. Md et al.,

, Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy, Circulation. 3 avr, vol.125, issue.13, pp.1605-1621, 2012.

W. Pa, M. Jb, . Baker-cs, D. Kannel-wb, and . Rb, Impact of atrial fibrillation on mortality, stroke, and medical costs, Arch Intern Med. 9 févr, vol.158, issue.3, pp.229-263, 1998.

. Friberg-j, H. Scharling, . Gadsbøll-n, J. Truelsen-t, C. Gb et al.,

, Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study), Am J Cardiol, vol.94, issue.7, pp.889-94, 2004.

W. Tj, L. Mg, . Levy-d, L. Vasan-rs, W. Ep et al., Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, Circulation. 17 juin, vol.107, issue.23, pp.2920-2925, 2003.

. Nieuwlaat-r, C. Capucci-a, O. Aj, A. Sb, D. Dw et al., Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J. nov, vol.26, issue.22, pp.2422-2456, 2005.

C. Sj, E. Md, Y. S. , R. Pa, . Wallentin-l et al.,

L. Investigators, Newly identified events in the RE-LY trial

, N Engl J Med, vol.363, issue.19, pp.1875-1881, 2010.

M. Patel-mr, . Kw, J. Garg, G. Pan, S. De et al., Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med. 8 sept, vol.365, issue.10, pp.883-91, 2011.

A. Granger-cb, M. Jh, . Jjv, . Lopes-rd, E. M. Hylek et al.,

, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med. 15 sept, vol.365, issue.11, pp.981-92, 2011.

. Haute-autorite-de and . Sante, Fibrillation auriculaire non valvulaire: quelle place pour les anticoagulants oraux ? mai, 2018.

C. Sj, E. Joyner-c, H. R. Diener-h-c, E. T. Golitsyn-s, and . Al, Apixaban in patients with atrial fibrillation, N Engl J Med. 3 mars, vol.364, issue.9, pp.806-823, 2011.

C. Sj, E. Md, Y. , E. Oldgren, J. Parekh-a et al., Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med. 17 sept, vol.361, issue.12, pp.1139-51, 2009.

. Singer, C. Y. De, F. Mc, B. Lh, P. Nk et al., The net clinical benefit of warfarin anticoagulation in atrial fibrillation, Ann Intern Med. 1 sept, vol.151, issue.5, pp.297-305, 2009.

. Perrin-a and . Rolland-y, Oral anticoagulant therapy in elderly patients, Ann Gérontologie. 1 sept, vol.3, issue.3, pp.189-96, 2010.

. Whittle-j, V. Wickenheiser-l, . Ln, . Sudlow-m, . Thomson-r et al., Prevalence of atrial fibrillation and eligibility for anticoagulants in the community, Arch Intern Med. 24 févr, vol.157, issue.4, pp.1167-71, 1997.

. Active, C. S. Investigators, J. Pogue, and . Hart-r,

. Pfeffer-m, E. T. Hohnloser-s, and . Al, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet Lond Engl. 10 juin, vol.367, issue.9526, pp.1903-1915, 2006.

A. Investigators, C. Sj, J. Pogue, H. Rg, H. Sh et al.,

, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med. 14 mai, vol.360, issue.20, pp.2066-78, 2009.

C. Van-walraven, H. Rg, S. De, L. A. , C. S. Petersen-p et al., Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient metaanalysis, JAMA, vol.288, pp.2441-2449, 2002.

G. Lip, The role of aspirin for stroke prevention in atrial fibrillation, Nat Rev Cardiol, vol.26, issue.10, pp.602-608, 2011.

R. Fuster-v, A. Le, C. Rw, C. Ds, . Hj et al., ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation. Circulation, vol.104, pp.2118-50, 2001.

. Haute-autorite-de and . Sante, L'audit clinique : bases méthodologiques de l'évaluation des pratiques professionnelles, 1999.

L. , P. Piot-o, S. Ma, C. Lavergne-t, and E. T. Al, Cost of care distribution in atrial fibrillation patients: the COCAF study, Am Heart J. janv, vol.147, issue.1, pp.121-127, 2004.

. Gage, . Bf, . Waterman-ad, . Shannon-w, M. Boechler et al., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA. 13 juin, vol.285, issue.22, pp.2864-70, 2001.

Y. Y. Wang-c, Z. W. , Y. J. , L. Gyh, and . Hong-k, Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis, Oncotarget, vol.12, issue.2017

N. N. Ogilvie-im, W. Sa, L. Cowell-w, . Gyh, H. Go-as et al., Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation: How Well Do Randomized Trials Translate Into Clinical Practice? JAMA, Am J Med. juill, vol.123, issue.7, p.2685, 2003.

A. Cohen-n, A. Gorelik-o, . Koopfer-m, E. T. Chachashvily-s, and . Al,

, Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission, Stroke. juin, vol.31, issue.6, pp.1217-1239, 2000.

. Dharmarajan-ts, A. Varma-s, L. As, and N. Ep, To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation, J Am Med Dir Assoc. janv, vol.7, issue.1, pp.23-31, 2006.

. Torn-m, . Bollen-wlem, . Van-der-meer, . Fjm, . Van-der-wall et al., Risks of oral anticoagulant therapy with increasing age, Arch Intern Med. 11 juill, vol.165, issue.13, pp.1527-1559, 2005.

J. Ce, L. Wk, and W. Bs, People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient-years of followup, J Am Geriatr Soc. avr, vol.53, issue.4, pp.655-664, 2005.

P. Bm, M. Ta, K. Lh, K. Ra, . Cushman-m et al., Incidence of and risk factors for atrial fibrillation in older adults, Circulation, vol.96, issue.7, pp.2455-61, 1997.

, Connaissez-vous les dispositifs d'auto surveillance de l'INR ? Oui Non Si oui, avez-vous des patients qui utilisent ce dispositif ? Oui Non

, Sur quels éléments cliniques et/ou biologiques reposent le suivi des ACO